Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.7392
-0.0175 (-2.31%)
At close: Nov 18, 2026, 4:00 PM EST
0.7490
+0.0098 (1.33%)
After-hours: Nov 18, 2026, 7:56 PM EST
Ocugen Revenue
Ocugen had revenue of $1.95M in the quarter ending September 30, 2026, with 11.36% growth. In the year 2025, Ocugen had annual revenue of $4.41M with 8.83% growth. That makes Ocugen the 40,163rd largest company in the world by revenue and 5,335th in the United States.
Revenue (ttm)
$4.41M
Revenue Growth
+8.83%
P/S Ratio
51.51
Revenue / Employee
$41,207
Employees
116
Market Cap
250.82M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.41M | 358.00K | 8.83% |
| Dec 31, 2024 | 4.06M | -1.98M | -32.82% |
| Dec 31, 2023 | 6.04M | 3.55M | 142.60% |
| Dec 31, 2022 | 2.49M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 43.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 8.00K | -18.00K | -69.23% |
| Dec 31, 2012 | 26.00K | -97.00K | -78.86% |
| Dec 31, 2011 | 123.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Protalix BioTherapeutics | 84.69M |
| Clinuvel Pharmaceuticals | 65.05M |
| Q32 Bio | 53.74M |
| Arcturus Therapeutics Holdings | 30.51M |
| Camp4 Therapeutics | 5.32M |
| Inovio Pharmaceuticals | 298.90K |
OCGN News
- 6 days ago - Ocugen Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 8 days ago - Ocugen, Celairis Therapeutics announce exclusive OCU400 license agreement - TheFly
- 8 days ago - Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN - GlobeNewsWire
- 12 days ago - Ocugen Proxy statement: Proxy filing - Filings
- 12 days ago - Ocugen Proxy statement: Proxy filing - Filings
- 14 days ago - Ocugen Earnings Call Transcript: Q3 2026 - Transcripts
- 14 days ago - Ocugen Earnings release: Q3 2026 - Filings
- 14 days ago - Ocugen Quarterly report: Q3 2026 - Filings